Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease

DISCUSSION: CSF apoB markedly associates with early tau dysregulation in asymptomatic subjects and identifies at-risk individuals predisposed to develop visuospatial cognitive decline over time.PMID:34590423 | DOI:10.1002/alz.12442

Source: The Journal of Alzheimers Association - September 30, 2021 Category: Psychiatry Authors: Cynthia Picard Nathalie Nilsson Anne Labont é Daniel Auld Pedro Rosa-Neto Alzheimer's Disease Neuroimaging Initiative Nicholas J Ashton Henrik Zetterberg Kaj Blennow John C B Breitner Sylvia Villeneuve Judes Poirier PREVENT-AD research group Source Type: research